Ingevity Corp (NGVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 132,600 | 118,000 | N/A | N/A |
| Depreciation Amortization | 32,300 | 33,000 | N/A | N/A |
| Income taxes - deferred | 2,200 | 2,000 | N/A | N/A |
| Accounts receivable | -4,800 | -11,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,900 | 14,000 | N/A | N/A |
| Other Working Capital | -23,800 | -27,000 | N/A | N/A |
| Other Operating Activity | -6,900 | 8,000 | 0 | 0 |
| Operating Cash Flow | $138,500 | $137,000 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -95,800 | -63,000 | N/A | N/A |
| Other Investing Activity | -1,000 | -1,000 | 0 | 0 |
| Investing Cash Flow | $-96,800 | $-64,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 2,800 | N/A | N/A | N/A |
| Other Financing Activity | -34,500 | -79,000 | 0 | 0 |
| Financing Cash Flow | $-31,700 | $-79,000 | $N/A | $N/A |
| Exchange Rate Effect | -1,600 | 2,000 | N/A | N/A |
| Beginning Cash Position | 11,500 | 16,000 | N/A | N/A |
| End Cash Position | 19,900 | 12,000 | N/A | N/A |
| Net Cash Flow | $8,400 | $-4,000 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 138,500 | 137,000 | N/A | N/A |
| Capital Expenditure | -101,800 | -63,000 | N/A | N/A |
| Free Cash Flow | 36,700 | 74,000 | 0 | 0 |